174
We report a 46-yr-old woman with ovarian carcinoma who developed porphyria cutanea tarda while undergoing treatment with cisplatin and cyclophosphamide.
 a 46-yr-old woman with ovarian carcinoma: Subject; 46-yr-old: Subject.Age; woman: Subject.Gender; porphyria cutanea tarda: Effect; cisplatin and cyclophosphamide: Treatment; cisplatin: Treatment.Drug; cyclophosphamide: Treatment.Drug; ovarian carcinoma: Treatment.Disorder; cisplatin: Combination.Drug; cyclophosphamide: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 46-yr-old woman with ovarian carcinoma: Subject; 46-yr-old: Subject.Age; woman: Subject.Gender; porphyria cutanea tarda: Effect; cisplatin and cyclophosphamide: Treatment; cisplatin: Treatment.Drug; cyclophosphamide: Treatment.Drug; ovarian carcinoma: Treatment.Disorder; cisplatin: Combination.Drug; cyclophosphamide: Combination.Drug